Cnb Bank Amgen Inc Transaction History

Cnb Bank

$215 Million
Q3 2024

A detailed history of Cnb Bank transactions in Amgen Inc stock. As of the latest transaction made, Cnb Bank holds 1,366 shares of AMGN stock, worth $361,293. This represents 0.2% of its overall portfolio holdings.

Number of Shares

1,366

Previous 1,371 0.36%

Holding current value

$361,293

Previous $428,000 2.8%

% of portfolio

0.2%

Previous 0.21%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$309.38 - $337.38 $1,546 - $1,686	-5 Reduced 0.36%	1,366 $440,000
Q2 2024 Aug 08, 2024	SELL	$262.75 - $319.31 $4,466 - $5,428	-17 Reduced 1.22%	1,371 $428,000
Q1 2024 May 02, 2024	SELL	$268.87 - $324.56 $1,344 - $1,622	-5 Reduced 0.36%	1,388 $394,000
Q4 2023 Jan 31, 2024	SELL	$255.7 - $288.46 $14,319 - $16,153	-56 Reduced 3.86%	1,393 $401,000
Q3 2023 Nov 02, 2023	SELL	$218.65 - $271.46 $40,450 - $50,220	-185 Reduced 11.32%	1,449 $389,000
Q2 2023 Aug 08, 2023	BUY	$214.27 - $253.37 $82,279 - $97,294	384 Added 30.72%	1,634 $362,000
Q1 2023 May 10, 2023	SELL	$225.79 - $275.2 $12,192 - $14,860	-54 Reduced 4.14%	1,250 $302,000
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $29,086 - $36,958	-127 Reduced 8.87%	1,304 $342,000
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $91,804 - $103,538	-409 Reduced 22.23%	1,431 $323,000
Q2 2022 Aug 19, 2022	SELL	$230.71 - $256.74 $126,659 - $140,950	-549 Reduced 22.98%	1,840 $448,000
Q2 2022 Aug 10, 2022	SELL	$230.71 - $256.74 $645,526 - $718,358	-2,798 Reduced 53.94%	2,389 $582,000
Q1 2022 Apr 13, 2022	BUY	$219.27 - $242.57 $114,020 - $126,136	520 Added 11.14%	5,187 $1.25 Million
Q4 2021 Jan 31, 2022	BUY	$198.88 - $227.6 $17,899 - $20,484	90 Added 1.97%	4,667 $1.05 Million
Q3 2021 Nov 02, 2021	BUY	$212.27 - $248.7 $90,639 - $106,194	427 Added 10.29%	4,577 $973,000
Q2 2021 Jul 29, 2021	SELL	$233.58 - $259.14 $19,854 - $22,026	-85 Reduced 2.01%	4,150 $1.01 Million
Q1 2021 May 03, 2021	SELL	$221.91 - $258.6 $203,935 - $237,653	-919 Reduced 17.83%	4,235 $1.05 Million
Q4 2020 Jan 27, 2021	SELL	$216.38 - $257.67 $4,327 - $5,153	-20 Reduced 0.39%	5,154 $1.19 Million
Q3 2020 Oct 26, 2020	BUY	$234.65 - $260.95 $50,215 - $55,843	214 Added 4.31%	5,174 $1.32 Million
Q2 2020 Jul 14, 2020	BUY	$197.81 - $242.74 $23,143 - $28,400	117 Added 2.42%	4,960 $1.17 Million
Q1 2020 May 13, 2020	BUY	$182.24 - $241.7 $246,388 - $326,778	1,352 Added 38.73%	4,843 $982,000
Q4 2019 Jan 27, 2020	BUY	$189.21 - $243.2 $117,499 - $151,027	621 Added 21.64%	3,491 $842,000
Q3 2019 Nov 04, 2019	BUY	$174.11 - $208.62 $223,905 - $268,285	1,286 Added 81.19%	2,870 $555,000
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $235,547 - $276,114	1,413 Added 826.32%	1,584 $292,000
Q1 2019 Apr 29, 2019	BUY	$180.87 - $203.88 $9,224 - $10,397	51 Added 42.5%	171 $33,000
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $5,811 - $6,527	35 Added 41.18%	120 $22,000
Q1 2018 May 11, 2018	SELL	$169.43 - $198.0 $8,471 - $9,900	-50 Reduced 37.04%	85 $15,000
Q4 2017 Feb 20, 2018	BUY	$168.79 - $188.59 $22,786 - $25,459	135	135 $23,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cnb Bank, based on Form 13F filings with the SEC.

News

Stay updated on Cnb Bank with notifications on news.

Account